4592 — SanBio Share News
0.000.00%
Table: Sanbio - 9-MTH group results
Table: Sanbio - 6-MTH group results
Table: Sanbio -Q1 group results
Table: Sanbio -2021/22 group results
Table: Sanbio -2021/22 parent results
Table: Sanbio - 9-MTH group results
Table: Sanbio - 6-MTH group results
Table: Sanbio -Q1 group results
Table: Sanbio -2020/21 parent results
Table: Sanbio -2020/21 group results
Table: Sanbio -2020/21 group forecast
Table: Sanbio - 9-MTH group results
Table: Sanbio - 6-MTH group results
Table: Sanbio -Q1 group results
Table: Sanbio -2019/20 parent results
Table: Sanbio -2019/20 group results
Table: Sanbio - 9-MTH group results
Table: Sanbio -2019/20 group forecast
Brief: SanBio Says U.S. FDA Granted Regenerative Medicine Advanced Therapy Designation For SB623